Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 8/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CCR9 | P51686 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | OXTR | P30559 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6176637 | 0.92 | IGF1R (0.40) | IGF1RKMT2ATP53OXTR | |
| SCHEMBL6174225 | 0.90 | MAPT (0.42) | IGF1RMAPTCYP2C9THRBKMT2A | |
| SCHEMBL6224943 | 0.87 | CCR9 (0.46) | MAPTCYP2C9THRBKMT2ACCR9 | |
| SCHEMBL6172473 | 0.87 | IGF1R (0.42) | IGF1R | |
| SCHEMBL6172456 | 0.86 | IGF1R (0.42) | IGF1R | |
| SCHEMBL6173351 | 0.85 | IGF1R (0.41) | IGF1R | |
| SCHEMBL6173746 | 0.84 | LMNA (0.42) | IGF1RCYP2C9KMT2A | |
| SCHEMBL6176971 | 0.83 | IGF1R (0.40) | IGF1RMAPTCYP2C9KMT2A | |
| SCHEMBL6175453 | 0.83 | IGF1R (0.40) | IGF1R | |
| SCHEMBL2941868 | 0.82 | IGF1R (0.60) | IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |